MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 30, 2008; DOI: 10.1124/mol.108.049015


0026-895X/08/7402-312-316$20.00
Mol Pharmacol 74:312-316, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Related Article
Right arrow All Versions of this Article:
mol.108.049015v1
mol.108.049015v2
74/2/312    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Gurevich, V. V.
Right arrow Articles by Gurevich, E. V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurevich, V. V.
Right arrow Articles by Gurevich, E. V.
Perspective

Rich Tapestry of G Protein-Coupled Receptor Signaling and Regulatory Mechanisms

Vsevolod V. Gurevich, and Eugenia V. Gurevich

Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee

G protein-coupled receptors (GPCRs) are the largest family of signaling proteins and the most common therapeutic targets. In the last 2 decades, impressive progress in the understanding of GPCR function has been achieved, driven largely by the idea of similarity of the molecular mechanisms underlying their signaling and regulation. However, recent comprehensive studies of signaling and trafficking of several GPCR subtypes, including endogenous M3 muscarinic and H1 histamine receptor and expressed cysteinyl leukotriene type 1 receptor in human embryonic kidney 293 cells, clearly demonstrate that each receptor is regulated by a unique set of molecular mechanisms involving different players. These data indicate that the "gold mine" of similarities is nearly exhausted and that extrapolation from one receptor to another is as likely to be misleading as illuminating. Further progress in the field requires careful analysis of the regulation of individual GPCR subtypes in defined cellular context. In this issue of Molecular Pharmacology, Luo et al. (p. 338) describe a complex pattern of the regulation of M3 muscarinic receptor signaling.


Received May 19, 2008; accepted May 27, 2008

Address correspondence to: Vsevolod V. Gurevich, Vanderbilt University, Department of Pharmacology, PRB 418, Nashville, TN 37232. E-mail vsevolod.gurevich{at}vanderbilt.edu.


Related articles in MolPharm:

M3 Muscarinic Acetylcholine Receptor-Mediated Signaling Is Regulated by Distinct Mechanisms
Jiansong Luo, John M. Busillo, and Jeffrey L. Benovic
MolPharm 2008 74: 338-347. [Abstract] [Full Text]  






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics